GVK Bio’s Ahmedabad facility cleared by USFDA
July 30th, 2012 - 10:22 pm ICT by IANSHyderabad, July 30 (IANS) GVK Biosciences, Asia’s leading contract research organisation Monday announced that its Ahmedabad clinical pharmacology unit successfully cleared the USFDA audit.
The GVK BIO Ahmedabad facility, commissioned in 2010, has three clinics with 110 beds.
The facility has already been inspected and approved by Drugs Controller General of India (DCGI), ANVISA-Brazil and the Turkish health ministry, the Hyderabad-based firm said in a statement here.
The Ahmedabad facility carries out bio-availability and bio-equivalence (BA/BE) studies that are submitted to various regulatory agencies including US Food and Drug Administration (USFDA), TGA (Australia), European regulatory agencies, Health Canada, ANVISA-Brazil and Turkey’s health ministry.
“The sponsor can now carry out BA/BE studies at either of our sites, Ahmedabad or Hyderabad, with a wider choice of population and capacities,” said Manni Kantipudi, CEO, GVK BIO.
The GVK BIO Hyderabad facility is a full service provider of BA/BE services with four clinics and 144 beds supported by a bio-analytical facility.
- Clinical drug trial centres in Andhra to be probed - Jun 25, 2011
- GVK Bio gets approval from Turkey for bioequivalence studies - Mar 18, 2009
- GVK BIO gets Frost & Sullivan best practices award - Nov 21, 2011
- GVK BIO to support global consortium - May 16, 2011
- Over 250 companies to participate in BioAsia 2012 - Feb 07, 2012
- Man undergoing drug test dies in Andhra Pradesh - Dec 07, 2008
- Controller clears clot-buster drug for human trial - Aug 17, 2012
- US health regulator approves Chennai drug plant - Jun 22, 2011
- Dr Reddy's launches anti-asthma tablets in US - Nov 20, 2010
- Ranbaxy boosts presence in Africa with malaria drug - May 11, 2012
- First bio-pharma company launched in Pakistan - Oct 01, 2011
- Britain's Bourn Hall opens second IVF clinic in India - Sep 07, 2012
- Ranbaxy settles issue with US health regulator - Dec 21, 2011
- Panel to look into irregularities in drug trials - May 11, 2012
- Swedish national drugged, robbed - Mar 14, 2011
Tags: ahmedabad, anvisa, ba, beds, clinical pharmacology unit, contract research organisation, controller general, dcgi, equivalence, food and drug, food and drug administration, full service provider, gvk bio, gvk biosciences, health canada, health ministry, hyderabad facility, regulatory agencies, tga australia, turkish health